wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36740744-C09D6E5C-A3A3-46CA-A9AF-7A9F3BF515DB
Q36740744-C09D6E5C-A3A3-46CA-A9AF-7A9F3BF515DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36740744-C09D6E5C-A3A3-46CA-A9AF-7A9F3BF515DB
A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments
P2860
Q36740744-C09D6E5C-A3A3-46CA-A9AF-7A9F3BF515DB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36740744-C09D6E5C-A3A3-46CA-A9AF-7A9F3BF515DB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dd880d4e39c9868945064cee6ace7ce86200320c
P2860
Erlotinib in advanced non-small cell lung cancer: efficacy and safety findings of the global phase IV Tarceva Lung Cancer Survival Treatment study.